Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Rituximab Objective Outcome Measures Trial in SLE
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL
- Status
- UNKNOWN
- Phase
- PHASE3
Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
- Status
- COMPLETED
- Phase
- PHASE1
The PROLONG Trial - Rituximab Maintenance Therapy in ITP
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases
- Status
- COMPLETED
- Phase
- PHASE3
Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety of Switching From Rituximab to Ocrelizumab in MS Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)
- Status
- UNKNOWN
- Phase
- PHASE2
Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2